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INTRODUCTION
Fascioliasis is caused by trematodes belonging to the genus 
Fasciola (F. hepatica and F. gigantica) [1,2]. Its infection is known 
to cause bile duct inflammation and biliary obstruction [3,4]. 
Infection with Fasciola spp. occurs when metacercariae are ac-
cidentally ingested through raw vegetation. The metacercariae 
exist in the small intestine, and move through the intestinal 
wall and peritoneal cavity to the liver where adults mature in 
the biliary ducts of the liver. The acute phase is characterized 
by migration of immature worms through the liver. Clinical 
symptoms are related to hemorrhage and inflammation, and 
are usually severe, including fever, abdominal pain, respiratory 
disturbances, and skin rashes. The chronic phase starts when 
the worms reach the bile ducts. Symptoms are non-specific and 
usually mild to moderate [5].
We present here a case of F. gigantica-induced biliary obstruc-
tion and cholestasis that was diagnosed and treated via endos-
copy and triclabendazole treatment. This is the first case which 
was treated via endoscopic biliary extraction during endoscop-
ic retrograde cholangiopancreatography (ERCP) and drug in 
Turkey. 
CASE REPORT
In January 2010, a 37-year-old woman complained of icter-
us, ascites, and pain in her right upper abdominal region. She 
was living in a village of southeast of Anatolia region, and she 
had sheeps and cows. She had the eating history of lettuce, mal-
low, dill, and parsley without washing. She had no history of 
using hepatotoxic drugs. On admission to our department, her 
temperature was 37.9˚C, and she had icterus, hepatomegaly, 
and ascites. Over the 3-month period, her weight dropped from 
70 kg to 58 kg. Laboratory findings revealed an increase in leu-
kocytes, aspartate aminotransferase (AST), alanine aminotrans-
ferase (ALT), and bilirubin levels. CT scans revealed reticular 
patterns at all segments of the liver parenchyme, and in affinity 
with each other about 6 cm in greatest diameter, lobulated 
contours in multiple views with some cystic lesions were de-
tected. After contrast agent injection, mild peripheral enhance-
ment of the lesions were seen in the majority (abscess-phleg-
mon was considered). She had yellow color ascites and sple-
nomegaly. ERCP was addressed at F. gigantica because of their 
different appearance. Her eosinophilia was about 26.4%. The 
IgE level was 1,170 IU/ml (normal: 0-350 IU/ml). The serum 
collected when the fluke emerged yielded a titer of 1:20,480 
by a standard ELISA protocol (reference: <1,160). In the asci-
tes, serum ascites albumine gradient (SAAG) was under 1.1. 
We applied ERCP procedure to the patient. We removed 7 live 
F. gigantica worms during the ERCP (Fig. 1). On the basis of its 
morphology and shape, the fluke was diagnosed as F. gigantica, 
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and a portion was kept in 70% ethanol (Fig. 2). The eggs of F. 
gigantica are seen in Fig. 3. A single dose of triclabendazole (3 
tablets, oral) was administered. After these therapy, clinical 
symptoms disappeared and the patient remained completely 
healthy.
DISCUSSION
F. gigantica is a parasitic flatworm of the class Trematoda, 
which causes tropical fascioliasis. It is regarded as one of the 
most important single platyhelminth infections of ruminants 
in Asia and Africa. Estimates of infection rates are as high as 
80-100% in some countries [1-5]. Despite the importance to 
differentiate between the infection by fasciolid species, due to 
their distinct epidemiological, pathological, and control char-
acteristics, there is, unfortunately, neither a direct coprological 
(excretion-related) nor an indirect immunological test is avail-
able for their diagnosis [6,7]. The quantification of the differ-
ent sizes and shapes of F. hepatica and F. gigantica from bovines 
has been achieved for the first time in natural allopatric popu-
lations [8]. Linear measurements, areas and ratios of gravid 
adults and eggs of F. hepatica (from France and Spain) and F. 
gigantica (from Burkina Faso) can be analyzed using a com-
puter image analysis system and an allometric model: (y2m- 
y2)/y2=c[(y1m-y1)/y1](b), where y1=body area or body 
length, y2=one of the measurements analyzed, y1m, y2m= 
maximum values towards which y1 and y2, respectively, and c, 
b=constants [8]. All the measurements overlap in the 2 fasci-
olids, apart from the distance between the ventral sucker and 
the posterior end of the body, body roundness, and body leng-
th/body width ratio. This method is useful for Fasciola species 
Fig. 1. Endoscopic retrograde cholangiopancreatography (ERCP) findings of the patient, footprints of parasites.
Fig. 2. Fasciola gigantica (A, alcohol-fixed worms; B, a whole 
worm)  recovered during ERCP of the patient.
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identification in countries where both species coexist. In tre-
matodiases, size and shape of the fluke eggs shed with feces 
are crucial diagnostic features because of their typically little 
intraspecific variability. In fascioliasis, the usual diagnosis dur-
ing the biliary stage of infection is based on the classification 
of eggs found in the stool, duodenal content, or bile [9]. Ac-
cording to these studies we can say that our case is a F. gigantica 
infection.
The specific differentiation of trematodiases in general can 
be made by either a morphological study of adult flukes or by 
molecular tools. In the case of liver fluke infections, cholangio-
grams are useful, and biliary fascioliasis is characterized by non-
specific biliary dilatation and single or multiple small filling 
defects, which represent flukes themselves. However, the con-
clusive diagnosis of biliary facioliasis can be made by direct 
identification of flukes obtained from endoscopic or surgical 
removal, or detection of typical eggs in bile from the duodenal 
tube. 
Symptoms of the hepatic phase, which begin about 1 month 
after the exposure to metacercariae, are fever, general malaise, 
fatigue, hepatomegaly, anorexia, weight loss, urticaria with der-
matographism, and peripheral blood eosinophilia. The symp-
toms may be absent in the case of light infections. The biliary 
phase may be asymptomatic or there may be symptoms relat-
ed to cholangitis and obstruction of the biliary tract due to the 
enlarging flukes. The biliary phase may last for months or years. 
Peripheral blood eosinophilia during this interval suggests he-
patobiliary fascioliases [10]. 
Parasite removal during ERCP is a therapeutic option in pa-
tients with acute obstructive cholangitis due to F. gigantica [11]. 
Triclabendazole at a single dose of 10 mg/kg is the chemother-
apeutic regimen of choice against fascioliasis [12]. The drug is 
active against both immature and adult parasites, with high 
cure rates. Our case had chronic and hepatobiliary phase of 
fascioliasis. ERCP findings of parasites was very interesting (such 
as foodprints of parasites) (Fig. 1). We think this is a highly 
specific appearance for fascioliasis. The present F. gigantica pa-
tient is the first case which was treated via endoscopic biliary 
extraction during ERCP and drug in Turkey. 
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